Navigation Links
Investigation Shows Threats, Restrictions Impose Severe Obstacles for Abortion Providers, Women Seeking Abortions

Center for Reproductive Rights Urges Governments, Public, Medical Community to Support Abortion Providers as Human Rights Defenders

NEW YORK, July 22 /PRNewswire-USNewswire/ -- Aggressive harassment, discriminatory legal restrictions and serious stigma are reducing the number of abortion providers and making abortions more difficult for women to obtain, according to a report released today by the Center for Reproductive Rights, a leading reproductive rights advocacy group.

The report, Defending Human Rights: Abortion Providers Facing Threats, Restrictions, and Harassment, documents a four-month investigation of challenges facing abortion doctors and clinics in six states: Alabama, Mississippi, Missouri, North Dakota, Pennsylvania and Texas. The research chronicles the death threats, break-ins at homes and offices and physical assaults providers face as they protect women's reproductive health.

"Dr. Tiller's murder focused attention on this problem for a moment, but people don't realize that abortion providers operate under siege, legal and physical, every single day," explained Nancy Northup, the Center's president.

In addition to harassment, abortion providers face a web of discriminatory legal restrictions that have no medical justification, but make abortions more costly and difficult to provide, the Center's research found. Among these are laws that require a mandatory "waiting period" before a woman can obtain an abortion, counseling requirements that force doctors to present a biased and sometimes inaccurate description of abortion and its consequences, and Ambulatory Surgical Center laws that serve no purpose other than to mandate costly and sometimes impossible facilities renovations.

The Center unveiled the report in a Washington, D.C. briefing for members of Congress and staff, accompanied by Congressman Jerrold Nadler (D-NY), abortion providers and representatives of major human rights organizations.

Amy Hagstrom Miller, the president and CEO of Whole Woman's Health in Texas, welcomed the report. "For more than 35 years, abortion providers have provided an oasis for women needing to contemplate the most fundamental of decisions safe from the stigma surrounding abortion," she said. "Women have always had and will always have abortions. The question is whether safe and legal providers are available to them."

The report also argues that because abortion providers enable women to realize basic human rights such as the rights to health, equality, life, and privacy, they should be recognized as human rights defenders. It urges the state and federal government to adopt international standards for protecting and supporting clinic workers.

The report describes the international legal framework for ensuring that human rights defenders can function safely and effectively. In addition to international agreements on international human rights, including reproductive rights, the United Nations adopted a Declaration on Human Rights Defenders in 1998 with the support of the United States. Recognizing that human rights defenders often face stigma and opposition, the Declaration requires States to protect these workers.

"As this important report makes clear, preserving the legal right to abortion is a necessary but not a sufficient condition for making women's reproductive rights effective in the United States," said Meghan Rhoad, researcher for the Women's Rights Division at Human Rights Watch. "Every day, medical professionals struggle against tremendous odds and at personal cost to give these rights meaning by ensuring access to abortion services. It is time for the government to stand with these human rights defenders."

Instead, the Center's research shows that state and local governments often work against abortion providers. For example, in the 2009 state legislative session alone, 23 bills restricting abortion were introduced in Texas and 18 were introduced in Mississippi.

"The result," said Northup, "is not just endangerment and marginalization of abortion providers, but a denial of rights for the one in three American women who will seek an abortion in their lifetimes. The number of abortion providers in the United States fell by 25% just between 1992 and 2005. Without providers, the right to abortion is meaningless."

Two of the states featured in the report, North Dakota and Mississippi, have only a single abortion provider. Nationwide, 87 percent of counties in the country lack an abortion provider, and nearly a quarter of the women in the U.S. must travel more than 50 miles to reach one.

The Center for Reproductive Rights uses the law to advance reproductive freedom as a fundamental right that all governments are obligated to protect, respect and fulfill.

SOURCE Center for Reproductive Rights
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
2. Investigational New Drug Application for Fat Melting Injections Cleared by the FDA
3. ECLIPSE data on effects of Otsukas investigational novel treatment, Tolvaptan
4. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
5. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
6. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
7. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
8. UGA vet school receives $1.18 million NIH grant for rabies vaccine investigations
9. Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations
10. Accentia announces investigational new drug application for Revimmune for refractory MS
11. Supratek Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SP1049C for the treatment of metastatic adenocarcinoma of the upper gastrointestinal tract
Post Your Comments:
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, ... evaluating the efficacy of its product and its disinfection protocol. This study is taking ... 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, ...
(Date:11/25/2015)... ... November 25, 2015 , ... In ... nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension ... Pioneers, nominated by the public, will receive special recognition throughout 2016 as part ...
(Date:11/25/2015)... ... 25, 2015 , ... Many people know of the common symptoms of low ... dry skin. But many people who find their cholesterol levels and weight are creeping ... thyroid, especially if they don’t have any of the other symptoms. , Thyroid hormone ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bunion ... in an early celebration of the early holiday shopping season. Starting Wednesday November ... (normally $33.95 ea). Black Friday promotional pricing is in addition to any automatic ...
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 2015  Thanks to a donor with a personal ... Center,s Sister Diane Grassilli Center for Women,s Health now ... San Francisco . Fred ... with a gift of $617,320 that allowed the Center ... Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) mammography ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... new market research report "Spine Biologics Market by Product Type ... Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), ... by MarketsandMarkets, the global market was valued at $1.90 Billion ... 2020, at a CAGR of 4.4% during the forecast period ...
Breaking Medicine Technology: